tiprankstipranks
Trending News
More News >
Bluebird bio Inc (BLUE)
:BLUE
US Market
Advertisement

Bluebird Bio (BLUE) Price & Analysis

Compare
Followers

BLUE Stock Chart & Stats


Bluebird Bio News

BLUE FAQ

What was Bluebird bio Inc’s price range in the past 12 months?
Currently, no data Available
What is Bluebird bio Inc’s market cap?
Currently, no data Available
When is Bluebird bio Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bluebird bio Inc’s earnings last quarter?
Currently, no data Available
Is Bluebird bio Inc overvalued?
According to Wall Street analysts Bluebird bio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Bluebird bio Inc pay dividends?
    Bluebird bio Inc does not currently pay dividends.
    What is Bluebird bio Inc’s EPS estimate?
    Bluebird bio Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Bluebird bio Inc have?
    Currently, no data Available
    What happened to Bluebird bio Inc’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Bluebird bio Inc?
    Currently, no hedge funds are holding shares in BLUE

    Company Description

    Bluebird bio Inc

    Bluebird Bio, Inc. (BLUE) is a biotechnology company specializing in the development of gene therapies for severe genetic diseases and cancer. The company focuses on developing therapies that address the underlying genetic causes of these conditions, primarily through the use of lentiviral-based gene therapies. Bluebird Bio's core products are designed to treat conditions such as beta-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

    Bluebird Bio (BLUE) Earnings & Revenues

    Currently, no data available
    Please return soon. This page is being updated.
    Similar Stocks
    Company
    Price & Change
    Follow
    Adicet Bio
    Precision BioSciences
    Repare Therapeutics
    ImageneBio
    Immuneering

    Ownership Overview

    2.01%97.99%
    Insiders
    2.01%
    Mutual Funds
    ― Other Institutional Investors
    97.99% Public Companies and
    Individual Investors

    Options Prices

    Currently, No data available
    ---
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis